In a cohort of 12 patients with T2DM, a single HBOT session reduced fasting plasma glucose by 19%, increased total insulin sensitivity by 34%, and improved mitochondrial bioenergetics in both skeletal muscle and adipose tissue compared with controls [10]. This evidence concerns the gene INS and type 2 diabetes mellitus.